This inventor holds 2 USPTO granted patents. Top assignees: Inspire Pharmaceuticals, Inc., The University of North Carolina at Chapel Hill. Active years: 2006-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Raleigh, NC (US) (2006)
- Springville, UT (US) (2011)
Company Filing History:
2 out of 91 
1 out of 1,330 
Years Active: 2006-2011
Title: Krzysztof Bednarski: Innovator in Pharmaceutical Composition
Introduction
Krzysztof Bednarski is a notable inventor based in Springville, UT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of platelet aggregation. With a total of 2 patents to his name, his work focuses on innovative methods for treating conditions related to thrombosis.
Latest Patents
Krzysztof Bednarski's latest patents include a pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation. This invention is directed to a method of preventing or treating diseases associated with platelet aggregation. The method involves administering a pharmaceutical composition that includes a non-nucleotide pyrimidine-based compound, specifically a P2Y receptor antagonist. This composition is effective in inhibiting platelet aggregation, which is crucial for treating thrombosis and related disorders. Another patent focuses on a method that binds P2Y receptors on platelets to inhibit ADP-induced platelet aggregation. This invention also includes novel compounds and pharmaceutical formulations that utilize mononucleoside 5'-monophosphates, mononucleoside polyphosphates, and dinucleoside polyphosphates.
Career Highlights
Throughout his career, Krzysztof has worked with reputable organizations such as Inspire Pharmaceuticals, Inc. and the University of North Carolina at Chapel Hill. His experience in these institutions has contributed to his expertise in pharmaceutical innovations.
Collaborations
Krzysztof has collaborated with notable individuals in his field, including James G Douglass, III and Sammy Ray Shaver. These collaborations have further enhanced his research and development efforts.
Conclusion
Krzysztof Bednarski is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact the treatment of platelet aggregation-related conditions. His innovative patents and collaborations reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile